Skip to main content
. 2022 Aug 10;11(8):1544. doi: 10.3390/antiox11081544

Figure 4.

Figure 4

Antioxidant enzymes correlate with response to therapy and survival in HGSOC patients. (A) Expression levels of SLC7A11 in HGSOC patients, grouped for their pathological response to platinum-based therapy (complete response vs. residual disease after completing the therapy). Statistical significance of differences in gene expression levels in responders (n = 432) and non-responders (n = 202) was evaluated by the Mann–Whitney test. (B,C) Kaplan–Meier estimates of survival obtained on the Kaplan—Meier plotter analyzing post-progression survival in HGSOC patients treated with platinum-based chemotherapy.